Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group
No Thumbnail Available
Authors
Rebbeck, T. R.
Friebel, T.
Wagner, T.
Lynch, H. T.
Garber, J. E.
Daly, M. B.
Isaacs, C.
Olopade, O. I.
Neuhausen, S. L.
van 't Veer, L.
Issue Date
2005
Volume
23
Issue
31
Type
Journal Article
Language
Keywords
Alternative Title
Abstract
Description
Citation
Rebbeck, T. R.; Friebel, T.; Wagner, T.; Lynch, H. T.; Garber, J. E.; Daly, M. B.; Isaacs, C.; Olopade, O. I.; Neuhausen, S. L.; van 't Veer, L.; Eeles, R.; Evans, D. G.; Tomlinson, G.; Matloff, E.; Narod, S. A.; Eisen, A.; Domchek, S.; Armstrong, K.; Weber, B. L. Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: The PROSE Study Group. Journal of Clinical Oncology. 2005, NOV 1. 23(31):7804-7810.
Publisher
License
Journal
Volume
Issue
PubMed ID
DOI
Identifier
ISSN
0732-183X
1527-7755
1527-7755
